Avascular Necrosis (Osteonecrosis): Pain, Weakness, Treatment & Recovery

Avascular necrosis describes focal or segmental death of cancellous bone and marrow elements after delivery of oxygen and nutrients falls below the tissue’s needs. In the hip, interruption of retrograde perfusion through circumflex anastomoses around the femoral neck renders the subchondral dome vulnerable; over weeks to months the dead segment can soften, fracture along a subchondral plane (the crescent sign when visible), and mechanically collapse. Living bone attempts peripheral revascularisation and repair, but if structural support fails before healing completes, articular congruity is lost and painful secondary degenerative change follows.

Because symptoms often lead imaging, nurses repeatedly meet patients at the cliff-edge between reversible marrow stress and irreversible collapse—making time-linked assessment, medication reconciliation, and safe mobilisation as important as any single radiograph.

Teams stage disease to communicate collapse risk and to match operations. Classical Ficat descriptions remain in bedside teaching; ARCO (Association Research Circulation Osseous) systems add MRI lesion sizing and extent language used in trials—local MDTs standardise the schema they document in referrals.

↔On a small screen, swipe or scroll sideways to see the full table.

Presentation hinges on site and stage. Hip-centred disease classically produces activity-related groin discomfort that can radiate to buttock, lateral thigh, or knee. Early on, passive and active ranges may stay surprisingly generous—a pattern that sometimes delays concern until imaging finally catches up.

Typical features

• Progressive mechanical pain worsened by impact loading or prolonged standing.
• Antalgic gait or reduced stride length; difficulty with shoes and socks as hip flexion aggravates symptoms.
• Later: rest pain, stiffness, and global motion loss once collapse supervenes.

Atypical or high-risk contexts

• Bilateral hip involvement—keep index of suspicion after unilateral MRI diagnosis when steroids, alcohol, or haemoglobinopathy dominate the timeline.
• Young adults on chronic immunosuppression who minimise complaints until vocational disability appears.
• Post-traumatic presentations blended with soft-tissue injury after fractures or hip dislocation reductions—follow orthopaedic surveillance even when acute films look satisfactory.

Aetiologies converge on compromised microvascular flow or intraosseous hypertension. Assigning cause guides prognosis (bilateral risk, recurrence) and modifiable exposures.

Modifiable or iatrogenic

• Prolonged or high cumulative glucocorticoid exposure—including programmes used to control systemic inflammation.
• Alcohol excess.
• Smoking and other vascular insults layered onto baseline risks (support cessation counselling where appropriate).

Non-modifiable or disease-linked

• Haemoglobinopathies such as sickle cell disease.
• Hip trauma, femoral neck fracture, or dislocation injuring retinacular vessels.
• Metabolic bone context: long-term steroids also accelerate osteoporosis—tie DXA or bone density scan planning to primary or endocrine pathways when protocol allows.

Clinical assessment

Correlate mechanical pain with ROM testing, gait observation, and neurovascular check. Map steroid bursts, antiretrovirals, alcohol, anticoagulation, and prior radiotherapy. In sickle populations, distinguish bone pain crisis from infection before anchoring solely on AVN.

Laboratory investigations

No serum test confirms AVN; labs support differentials (infection, inflammatory flare) and perioperative risk (renal panel, clotting, haemoglobin).

Imaging

• Radiographs: screen for sclerosis, cystic change, crescent, collapse—may lag symptoms.
• MRI: defines marrow signal abnormality, subchondral separation, and estimates lesion extent.
• CT: surgeons sometimes request fine-detail segment geometry for pre-operative templating.

Criteria / classification in practice

Combine ARCO/Ficat stage, lesion size, and whether collapse is present to stratify hip-preserving candidacy—final decisions stay with orthopaedics and radiology.

↔On a small screen, swipe or scroll sideways to see the full table.

Treatment intent moves from preserving structural integrity before collapse to restoring function after collapse via resurfacing or replacement—always align nursing plans with signed weight-bearing and analgesic orders.

First-line / conservative (early disease)

• Analgesia ladder, activity modification, physiotherapy targeting hip stabilisers.
• Bisphosphonates, anticoagulants, hyperbaric oxygen, and electrical stimulation appear in literature but require specialist selection—not default ward orders.

Joint-preserving surgery

• Core decompression ± bone graft or biologics aimed at reducing intraosseous pressure and supporting revascularisation before collapse.
• Osteotomy or vascularised graft options in selected geometry—post-op partial weight-bearing is common; missed restrictions risk hardware failure.

Definitive reconstruction

• Total hip arthroplasty (and occasionally resurfacing in narrow indications) when collapse or secondary arthritis dominates rehabilitation potential.

Special populations

• Sickle cell disease: optimise haematology input, hydration balance, and infection surveillance perioperatively.
• Chronic steroid dependence: coordinate endocrine osteoporosis mitigation where appropriate—do not independently stop steroids.
• Renal impairment: adjust perioperative fluids and analgesic choice with pharmacy.

• Detection → imaging: flag new mechanical hip pain on glucocorticoids or sickle protocol patients for same-week clinician review.
• Threshold → action: MRI-positive pre-collapse disease triggers orthopaedic MDT documentation within days in most tertiary models—not “routine elective” months later.
• Treatment failure: escalating rest pain, declining independent transfers, or narcotic requirements rising without imaging improvement suggests progression—reconcile patient statements with orthopaedic follow-up cadence.
• Referral package: include weight-bearing status, occupation, imaging discs/links, and VTE history.
• Post-operative monitoring: neurovascular checks per local arthroplasty pathway, DVT prophylaxis administration verification, haemoglobin drift after blood loss.

Bedside monitoring checklist

• Pain scores at rest and with physiotherapy; bowel regimen if opioids escalate.
• Functional mobility (distance, device dependence) each shift after surgery.
• Skin integrity over protruding trochanters when gait is antalgic.

• Avascular progression to bilateral hips—adjust counselling and aids provisioning proactively.
• Secondary osteoarthritis and limb-length concerns after collapse.
• Deep infection, periprosthetic fracture, or dislocation after arthroplasty—follow institutional arthroplasty red-flag education.
• Opioid-induced delirium, constipation, and falls in older adults juggling multimorbidity.

Clinician-facing prevention means rationalising steroid courses via disease specialists, documenting cumulative exposure, maintaining bone-protection pathways for patients on long-term glucocorticoids, and ensuring trauma patients complete scheduled post-injury imaging. Alcohol reduction and smoking cessation counselling remain relevant vascular health levers when patients are engaged in shared decision-making.

Prognosis tracks stage at treatment: small pre-collapse lesions treated promptly sometimes stabilise; once large-scale collapse occurs, durable nonsurgical control becomes unlikely and arthroplasty quality-of-life gains dominate—yet implant longevity, activity restrictions, and medical comorbidities still frame realistic expectations. Bilateral disease and ongoing toxic exposures worsen long-term function regardless of index surgery success.

Communication

Translate MRI terminology into functional impacts: what weight bearing means for work duties, childcare, or driving (per local policy). Document exact assistive devices issued.

Medication safety

Reconcile NSAIDs against renal function and surgical timing; verify anticoagulant holds only through anaesthesia-approved pathways.

Escalation triggers

• Febrile, toxic patient with hip pain—consider septic joint workup in parallel with AVN history.
• Sudden neurovascular deficit post injury or post reduction—activate emergency orthopaedics.
• New chest pain or hypoxia after hip surgery—invoke PE protocol per institutional criteria.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and a compact cloze on the topic of avascular necrosis of the femoral head (and other sites), the modifiable risk-factor pathway, MRI staging and the joint-preserving (core decompression) vs joint-replacement decision.